EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling

Maria Belland Olsen, Mieke C Louwe, Kuan Yang, Jonas Øgaard, Tuva Børresdatter Dahl, Ida Gregersen, Katrine Alfsnes, Knut H Lauritzen, Sarah Louise Murphy, Muhammad Shakil Ahmed, Pål Aukrust, Leif Erik Vinge und 4 weitere

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Maria Belland Olsen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute for Clinical Medicine, Faculty of Medicine,…. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Angiotensin II, Mice, Inbred C57BL, Vascular Remodeling. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Throne Holst Foundation, South-Eastern Norway Regional Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specialized pro-resolving mediators (SPMs) are key effectors of resolution of inflammation. This is highly relevant for cardiac and vessel remodeling, where the net inflammatory response contributes to determine disease outcome. Herein, we used a mice model of angiotensin (Ang)-II-induced hypertension to study the effect of the SPM Resolvin D2 (RvD2), on hypertension and cardiac remodeling. By using subcutaneous osmotic minipumps, mice were treated with PBS or Ang-II in combination with or without RvD2 for two weeks. Mice receiving RvD2 gained less blood pressure increase compared to Ang-II alone. Surprisingly, however, examination of intracardiac arteries revealed that RvD2 treatment in combination with Ang-II exacerbated Ang-II-induced fibrosis. Measures of vascular smooth muscle cell dedifferentiation correlated with the level of vascular remodeling, indicating that this dedifferentiation, including increased proliferation and migration, is a contributing factor. RNA sequencing of left ventricle cardiac tissue supported these findings as pathways related to cell proliferation and cell differentiation were upregulated in mice treated with Ang-II in combination with RvD2. Additionally, the RNA sequencing also showed upregulation of pathways related to SPM metabolism. In line with this, Mass spectrometry analysis of lipid mediators showed reduced cardiac levels of the arachidonic acid derived metabolite leukotriene E4 in RvD2 treated mice. Our study suggests that continuous infusion through osmotic minipumps should not be the recommended route of RvD2 administration in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsAngiotensin IIMice, Inbred C57BLVascular RemodelingBlood PressureAnimalsMaleMiceHypertension

Stichwörter der Autor:innen

Angiotensin IIHypertensionResolvin D2Vascular remodeling

Substanzen

resolvin D2Docosahexaenoic AcidsAngiotensin II

Autor:innen und Institutionen

  • Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: maribol@medisin…
  • Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
  • Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Section of Clinical Immunology and…
  • Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Institute for Surgical Research, Oslo University Hospital, Oslo, Norway; Department of Medicine, Diakonhjemmet Hospital, Oslo, Norw…

Förderung

  • Throne Holst Foundation
  • South-Eastern Norway Regional Health Authority

Zitieren

APA

Olsen, M. B., Louwe, M. C., Yang, K., Øgaard, J., Dahl, T. B., Gregersen, I., Alfsnes, K., Lauritzen, K. H., Murphy, S. L., Ahmed, M. S., Aukrust, P., Vinge, L. E., Yndestad, A., Holven, K. B., Halvorsen, B., & Fosshaug, L. E. (2024). Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150706

Vancouver

Olsen MB, Louwe MC, Yang K, Øgaard J, Dahl TB, Gregersen I, et al. Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150706

BibTeX
@article{Olsen2024,
  author = {Olsen, Maria Belland and Louwe, Mieke C and Yang, Kuan and Øgaard, Jonas and Dahl, Tuva Børresdatter and Gregersen, Ida and Alfsnes, Katrine and Lauritzen, Knut H and Murphy, Sarah Louise and Ahmed, Muhammad Shakil and Aukrust, Pål and Vinge, Leif Erik and Yndestad, Arne and Holven, Kirsten B and Halvorsen, Bente and Fosshaug, Linn Elisabeth},
  title = {Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150706}
}
Kostenlos starten →